Astera Labs (NASDAQ:ALAB) Trading 2.1% Higher – Time to Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price shot up 2.1% during trading on Friday . The company traded as high as $203.50 and last traded at $199.79. 4,479,711 shares were traded during trading, a decline of 17% from the average session volume of 5,385,805 shares. The stock had previously closed at $195.65.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: JPMorgan raised its price target on Astera Labs to $280 from $205 and kept an overweight rating, signaling strong confidence in further upside after the company’s latest results. Benzinga
• Positive Sentiment: Needham lifted its price target to $260, while other reports cited positive forecasts from JPMorgan and Stifel, adding to the bullish analyst momentum around ALAB. Astera Labs (NASDAQ:ALAB) Price Target Raised to $260.00 at Needham & Company LLC
• Positive Sentiment: Commentary around the stock highlighted Astera Labs as a long-term momentum name and a beneficiary of AI connectivity demand, suggesting investors see durable growth tied to datacenter buildouts and server interconnect products. Why Astera Labs, Inc. (ALAB) is a Top Momentum Stock for the Long-Term
• Positive Sentiment: Several pieces emphasized strong AI connectivity demand and Scorpio expansion, with upbeat takes on the company’s positioning in the datacenter market helping support the stock. Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised
• Neutral Sentiment: Post-earnings analysis was mixed: bulls pointed to strong growth, but critics noted rising costs, competition, and a premium valuation, which could cap near-term upside. Should Investors Buy, Hold, or Sell ALAB Stock Post Q1 Earnings?
• Neutral Sentiment: Astera Labs’ Q1 2026 earnings transcript kept attention on the company’s strong revenue growth and guidance, but the transcript itself does not add a new catalyst beyond the already reported results. Astera Labs (ALAB) Q1 2026 Earnings Transcript
• Negative Sentiment: The main downside risk is valuation: after a strong run and multiple target hikes, some investors may worry the stock already prices in a lot of future growth.

Analysts Set New Price Targets

A number of analysts have recently weighed in on ALAB shares. UBS Group began coverage on Astera Labs in a research report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 target price for the company. Roth Mkm reaffirmed a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a research note on Wednesday. Morgan Stanley upped their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday. Susquehanna upped their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday. Finally, Weiss Ratings upgraded shares of Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. Fifteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $229.65.

Astera Labs Trading Up 2.1%

The firm has a market capitalization of $34.22 billion, a P/E ratio of 134.99, a P/E/G ratio of 4.21 and a beta of 3.35. The firm has a 50-day moving average of $143.77 and a two-hundred day moving average of $153.99.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 19.36% and a net margin of 26.72%.The business’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 1.48 EPS for the current fiscal year.

Insider Activity at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the transaction, the director directly owned 319,863 shares in the company, valued at $34,420,457.43. This represents a 36.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 10,188 shares of the company’s stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $175.45, for a total transaction of $1,787,484.60. Following the transaction, the chief executive officer owned 4,069,134 shares of the company’s stock, valued at approximately $713,929,560.30. This represents a 0.25% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 1,064,888 shares of company stock valued at $150,764,723. Company insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently modified their holdings of the company. Assetmark Inc. grew its position in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after acquiring an additional 101 shares during the last quarter. Reflection Asset Management bought a new position in Astera Labs in the fourth quarter valued at about $25,000. Smartleaf Asset Management LLC boosted its stake in shares of Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares in the last quarter. Hilltop National Bank grew its holdings in shares of Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC bought a new stake in shares of Astera Labs during the fourth quarter worth about $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.